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Abstract: 
Model organisms are widely used in research, especially in the context of complex 
situations. One model organism that has been widely used is the common fruit fly, Drosophila 
melanogaster (D. mel). D. mel are most commonly used in the context of genetics, but they have 
also been widely used in research focusing on general anesthetics. One value that has not been 
measured in D. mel, however, as it relates to general anesthetics, is the decrement times. This is 
what the present research set out to determine. The anesthetics studied in this research were 
isoflurane and sevoflurane. Flies were exposed to 40 µL of anesthetic in a centrifuge tube for 10 
minutes, after which the flies were allowed a recovery period of a set time. In the case of the 
control group, this time was 0 minutes. The anesthetic was then extracted using dichloromethane 
(DCM) and enflurane was added as an internal standard. The decrement times of male flies with 
isoflurane were found to be around 30 seconds for the 50% decrement, 2 minutes for the 80%, 
and 3 minutes for the 90% decrement. For female flies the values found with isoflurane were 
found to be about 30 seconds for the 50% decrement and 4 minutes for the 80% decrement. The 
values found for the 50% decrement time of sevoflurane were about 5 minutes for the female 
flies and 2 minutes for the male flies, but the values found in female flies with sevoflurane were 
not consistent. Though the data with sevoflurane were inconsistent, those collected with 
isoflurane give valuable insight into general anesthetics. This information can be used in future 
work involving drosophila flies and anesthetics to gain a deeper understanding of how 
inhalational anesthetics work. 
 
Introduction: 
The first publicized use of anesthetics was nearly 200 years ago in 1846, and since then 
the use of anesthetics has become more common and safer for the patient.15,17 There are still 
many dangers of anesthetics, however, especially associated with prolonged and early exposure 
to anesthetic gases.4,5,12,14,16 Although many discoveries have been made, there are still many 
aspects of anesthesia that are not well understood. One way to further understand anesthesia is 
through the use of model organisms. A recent discovery that used model organisms found that 
stimulation or inhibition of certain neurons in the hypothalamus of mice had a correlation with 
quality and duration of sleep.6 To be used as a model organism, research must indicate that the 
organism responds to given stimuli in a way similar to how humans respond. This data can then 
be used to better understand the stimuli in humans. The fruit fly, Drosophila melanogaster (D. 
mel)  ̧is commonly used as a model organism, especially in the context of genetics, and has been 
said to be the model organism for genetics.13 While genetics is the arena where D. mel has the 
most acclaim, the organism can be a model in many other applications. 
            One application for which D. mel has been used as a model is with anesthetics. 
Karunanithi et al. explored how D. mel are similar to humans in the way their minds and bodies 
react to anesthetics.7 They present a basic overview of anesthesia and how it affects different 
levels of consciousness and discuss a few experiments with anesthetics and D. mel, such as using 
propofol-laced food in order to monitor activity of flies with different levels of anesthesia 
exposure. In 2017, MacMillan et al. explored the effects of isoflurane and sevoflurane 
anesthetics on many different aspects of health in D. mel including fecundity, starvation, and 
temperature tolerances.9 MacMillan et al. found that D. mel generally recover more quickly from 
sevoflurane than isoflurane after similar exposure times. It was also found that with increased 
exposure time, the recovery time was more sex-dependent in isoflurane than in sevoflurane and 
that the fecundity of female flies was not significantly affected by either sevoflurane or 
isoflurane. 
 D. mel have been used in many different experiments to determine how anesthesia affects 
different organisms and how its effects can change based on genetics and sex.3,7,8,9,10,18 Many 
properties of anesthetics have been measured in the organism. One property of anesthetics that is 
very important to those who work in the field of anesthesiology is the minimum alveolar content 
(MAC). The minimum alveolar content is a measure of how saturated the alveoli in the lungs 
must be with an anesthetic before approximately half of all humans will not react to a surgical 
incision.11 Zalucki et. al. found the MAC value in D. mel to be 0.2-0.6% depending on the 
criteria used to determine if the fly is conscious.18 Consciousness was determined through a 
startle response, but the MAC was found to be higher if the test involved what the authors 
described to be more complex behavior, such as reacting to a light beam rather than reacting to a 
vibration. 
One property of anesthetics that has not been measured in D. mel is the decrement times. 
The decrement time of an anesthetic is defined as the amount of time necessary for a given 
percentage of that anesthetic to have left the organism.11 In 1997, Bailey calculated the 
decrement times of isoflurane, sevoflurane, enflurane, and desflurane in humans.2 Bailey found 
that after 6 hours of exposure, enflurane has the longest 90% decrement time, at about 100 
minutes, with isoflurane at 86 minutes, sevoflurane at 65 minutes, and desflurane being 
considerably lower than the rest at 14 minutes. 
Knowing the decrement times of different anesthetic gases in D. mel will further establish 
the organism as a model for volatile anesthetic properties in humans. In this experiment, the 
decrement times of isoflurane and sevoflurane in male and female D. mel will be measured using 
gas chromatography-mass spectrometry (GC/MS). 
 
Materials and Methods: 
The method for this experiment was largely new, though various other previously 
published experiments were consulted in choosing an internal standard, administration of 
anesthetic, and deciding the GC/MS method.1,9,10 The flies used were wild type drosophila flies 
ordered from Carolina (catalog number 172100). They were kept in culture vials and fed 
drosophila fly medium with yeast placed in the media and hydrated using sterile water. Flies 
were allowed to propagate and were transferred to new vials every month or so. The vials were 
stored in a Fisher Scientific 307C Isotemp Low Temperature Incubator/Freezer set to 21.0 ˚C. 
No special attention was paid to using virgin female flies, thus flies were removed from vials and 
tested when necessary. 
Due to the fact that male and female drosophila flies have been found to have different 
recovery times, which would imply different decrement times, the flies were first sorted male 
and female.9 This was done by removing flies from the culture vial to a new vial without 
medium. Flynap was then administered to the flies until they were all asleep, not exceeding two 
minutes of exposure. The flies were then placed on a notecard under a dissection microscope and 
sorted into two piles based on sex. Images of male and female flies have been included. It should 
also be noted that female flies are typically larger than male flies, but because this can vary based 
on genetics, all flies were sexed by flipping the fly over and checking the genitalia. 
 
Image 1. Male drosophila fly. Notice the darker genitals and smaller size. 
 
 
Image 2. Female drosophila fly. Notice the lighter, smooth genitals and larger size. 
After the flies were sorted, they were placed in empty culture vials overnight, to allow 
them to recover and to ensure that the Flynap had no effect on responses to the anesthetics being 
tested. The following day, the flies were removed from the culture vials into a conical centrifuge 
tube. A foam disc was then inserted into the top of the tube, to ensure that the flies would not be 
able to escape. Into this foam disc was injected 40 µL of isoflurane or sevoflurane, depending on 
which anesthetic was being tested. The cap was placed on the centrifuge tube to keep the 
anesthetic inside the tube, and the flies breathed the anesthetic for 10 minutes. At 10 minutes, the 
flies were transferred to a glass centrifuge tube, and were either allowed to recover, or, in the 
case of the control group, immediately killed by pouring dichloromethane (DCM) into the vial. 
At this point, an enflurane internal standard was also added to the vial. The internal standard was 
added as soon as possible to ensure any mistakes made during the procedure also affected the 
concentration of internal standard. The internal standard solution was made by diluting 40 µL of 
enflurane in DCM to a total volume of 10 mL. 
The flies were then squished using a glass stir rod, to extract all of the anesthetic from 
their bodies by the DCM. This solution was then removed from the vial and diluted to 5 mL, in 
order to be sure that every trial was the same volume, no matter how much was removed into the 
GC/MS vial. 
Before data was collected, the response factor of the internal standard being used, 
enflurane, was calculated with both isoflurane and sevoflurane. These were run in equal 
concentrations and the following equation was used to calculate response factor (F): 
𝐹 ∗
𝐴𝑟𝑒𝑎𝐼𝑆
[𝐼𝑆]
=
𝐴𝑟𝑒𝑎𝐴
[𝐴]
 
Where “IS” represents the internal standard, and “A” represents the analyte, which was 
either isoflurane or sevoflurane, depending on the trial. Two trials were run for both isoflurane 
and sevoflurane, and these values can be found in table 1. 
Table 1 The values measured to calculate response factor (F) of isoflurane and sevoflurane with enflurane. 
Because equal volumes of internal standard (IS) and analyte were used, the ratio of analyte to IS was equal to F. The 
average of the two runs was then calculated for use later. 
Trial 
Analyte 
Peak Area 
Enflurane 
Peak Area 
Area Ratio 
(analyte/IS) 
 Response 
Factor (F) Average F 
Isoflurane 1 1257948 182306 6.900  6.900 6.945 
Isoflurane 2 1311796 187665 6.990  6.990 - 
Sevoflurane 1 115502 186218 0.620  0.620 0.626 
Sevoflurane 2 120471 190880 0.631  0.631 - 
 
The GC/MS used was a Shimadzu GCMS-QP2010 SE and the column used was a Rtx-
5MS column of length 30.0 m, diameter 0.25 mm, and thickness 0.25 µm. Many methods and 
solvents were tested to find one suitable. The solvent used was dichloromethane (DCM), but 
because DCM elutes later than isoflurane, sevoflurane, and enflurane, the mass spectrometer 
sensor was turned off around the 2-minute mark to avoid bombarding the sensor. Typically, the 
solvent elutes first, thus there is a solvent cut-off time, meaning the sensor waits to turn on until 
after the solvent has eluted. But because the solvent eluted later than the compounds being 
analyzed, it was decided to turn the sensor off after the analytes were measured. 
The method used was adapted from MacMillan et al. and was as follows.11 The column 
oven temperature was 30.0 ˚C. The injection temperature was 200.0 ˚C. A split injection mode 
was used with a split ratio of 1:50.0. The total flow was set to 54.7 mL/min with a column flow 
of 1.01 mL/min. The column oven temperature started at 30.0 ˚C and held at that temperature for 
4.00 minutes. The temperature then increased at a rate of 40.00 ˚C/min to a temperature of 140.0 
˚C, which was held for 5.00 minutes. 
 
Data and Discussion: 
After exposing the flies to anesthetics and extracting them with DCM, the sample was 
analyzed by the method described above. The data collected have been compiled below for both 
female and male flies and for isoflurane and sevoflurane. 
Table 2 Data for isoflurane in female flies. Percent decrement is calculated based on the control group. 
Trial 
Number 
of flies 
Isoflurane 
peak area 
Enflurane 
peak area 
Amount of 
isoflurane Isoflurane/fly 
Percent 
decrement 
Control 30 15380 5983 1.48x10-3 4.94x10-5 0 
0.5 min recovery 21 5106 5388 5.46x10-4 2.60x10-5 47.34 
1 min recovery 30 7097 5447 7.50x10-4 2.50x10-5 49.31 
2 min recovery 31 3751 5053 4.28x10-4 1.38x10-5 72.05 
3 min recovery 32 4471 4496 5.73x10-4 1.79x10-5 63.73 
4 min recovery 26 3350 6305 3.06x10-4 1.18x10-5 76.15 
 
The amount of isoflurane was calculated by using the same equation used to calculate F. 
Thus, the value calculated for the 0.5-minute recovery trial was calculated as follows: 
𝐹 =
(𝐴𝑟𝑒𝑎𝑎𝑛𝑎𝑙𝑦𝑡𝑒/𝐴𝑟𝑒𝑎𝐼𝑆)
([𝑎𝑛𝑎𝑙𝑦𝑡𝑒] [𝐼𝑆])⁄
 
[𝑎𝑛𝑎𝑙𝑦𝑡𝑒] = (
𝐴𝑟𝑒𝑎𝑎𝑛𝑎𝑙𝑦𝑡𝑒
𝐴𝑟𝑒𝑎𝐼𝑆
⁄
𝐹
)([𝐼𝑆])  
The value used for the concentration of internal standard ([IS]) was 0.004, because the 
internal standard was prepared by diluting 40 µL to 10.00 mL with DCM. The value calculated 
for the concentration of anesthetic was then divided by the number of flies in that trial, to 
standardize the amount of anesthetic present. 
Table 3 Data for isoflurane in male flies. Percent decrement is calculated based on the control group. 
Trial 
Number 
of flies 
Isoflurane 
peak area 
Enflurane 
peak area 
Amount of 
isoflurane Isoflurane/fly 
Percent 
decrement 
Control 29 21681 5739 2.18x10-3 7.50x10-5 0 
0.5 min 
recovery 29 9010 4958 1.05x10-3 3.61x10-5 51.90 
1 min recovery 21 2816 4505 3.60x10-4 1.71x10-5 77.15 
2 min recovery 32 3978 4598 4.98x10-4 1.56x10-5 79.24 
3 min recovery 25 1689 6202 1.57x10-4 6.27x10-6 91.64 
4 min recovery 23 1414 5607 1.45x10-4 6.31x10-6 91.58 
 
Table 4 Data for sevoflurane in female flies. Percent decrement is calculated based on the control group. Notice the 
very low percent decrement after 2 minutes of recovery. 
Trial 
Number 
of flies 
Sevoflurane 
peak area 
Enflurane 
peak area 
Amount of 
sevoflurane Sevoflurane/fly 
Percent 
decrement 
Control 28 4247 5407 5.02x10-3 1.79x10-4 0 
2 min recovery 30 4905 6011 5.22x10-3 1.74x10-4 3.04 
5 min recovery 31 1740 4714 2.36x10-3 7.61x10-5 57.55 
8 min recovery 34 2969 4167 4.56x10-3 1.34x10-4 25.30 
10 min 
recovery 25 0 4707 0 0 100 
 
Table 5 Data for sevoflurane in male flies. Percent decrement is calculated based on the control group. 
Trial 
Number 
of flies 
Sevoflurane 
peak area 
Enflurane 
peak area 
Amount of 
sevoflurane Sevoflurane/fly 
Percent 
decrement 
Control 31 7897 4598 1.10x10-2 3.54x10-4 0 
1 min recovery 29 2081 4922 2.70x10-3 9.32x10-5 73.68 
2 min recovery 27 4277 5918 4.62x10-3 1.71x10-4 51.69 
3 min recovery 39 4560 9534 3.06x10-3 7.84x10-5 77.86 
5 min recovery 32 4619 8626 3.42x10-3 1.07x10-4 69.80 
7 min recovery 22 0 5304 0 0 100 
 
The decrement times of isoflurane and sevoflurane in D. mel have not been measured and 
published to date. In order to measure this, male and female flies were separately exposed to 40 
µL of isoflurane or sevoflurane for 10 minutes, killed, and the anesthetic was extracted using 
dichloromethane. The relative amounts of anesthetic were measured using gas chromatography-
mass spectrometry, and it was found that the 90% decrement times for isoflurane for male flies 
was about 3 minutes. The 50% decrement times were also found to be around 30 seconds for 
female flies and slightly less than this for male flies, though an exact number for male flies was 
unknown due to the difficulty of extracting the anesthetic that quickly. The highest decrement 
times found for isoflurane in the female flies was the 80% decrement time at a little longer than 4 
minutes. 
The decrement times of sevoflurane are harder to determine based on the data collected. 
For female flies, the 50% decrement time was found to be a little under 5 minutes, but with a 
recovery time of 8 minutes, the decrement was found to be only 25%. A trial with a recovery 
time of 10 minutes using female flies found no sevoflurane peak, so it can be said that the 100% 
decrement time is somewhere between 8 minutes and 10 minutes. For male flies using 
sevoflurane, the data was similarly inconsistent. Like with the female flies, the only thing that 
can be said about the decrement times of sevoflurane in male flies is that the 100% decrement 
time is somewhere between 5 minutes and 7 minutes, as no sevoflurane peak was found after a 
recovery time of 7 minutes. 
One possible reason for the inconsistency in the data for sevoflurane is that sevoflurane 
may be metabolized by D. mel in some way that is unknown and that can occur at different rates 
under different circumstances. Though the environment during collection of data was never 
greatly changed, there may be some unknown factor that caused this change in metabolism. 
Conclusion: 
As mentioned before, the decrement times of anesthetics in Drosophila melanogaster 
have yet to be published, even though D. mel is a common model organism. Though the data 
collected using sevoflurane were inconsistent, the values found for isoflurane showed 
consistency and would be able to be used in future work involving drosophila flies and 
anesthetics to gain a deeper understanding of how inhalational anesthetics work. 
This experiment is limited by the fact that the data must be interpreted in the context of 
the procedure conducted. That is, the flies were exposed to anesthetic for ten minutes, whereas in 
some experiments they may be exposed for much longer than that. The amount of anesthetic the 
flies were exposed to, however, saturates the centrifuge tube and makes adding any more 
anesthetic superfluous.9 While this does present a challenge when applying this data to other 
situations, the data is nonetheless novel and can still be helpful in future research. 
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